Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series
Incidence of EGCT in Australia is consistent with published literature. Treatment patterns reflect international practices. Primary mediastinal non-seminoma has the poorest outcomes. Primary retroperitoneal and primary mediastinal seminomas have excellent outcomes.
Authors
- Chun Loo Gan (ORCID: https://orcid.org/0000-0003-2576-9310)
- Elizabeth Liow (ORCID: https://orcid.org/0000-0002-3598-5095)
- Peter Grimison (ORCID: https://orcid.org/0000-0002-2653-1657)
- Shomik Sengupta
- Anna Kuchel (ORCID: https://orcid.org/0000-0001-8580-2974)
- James Lynam (ORCID: https://orcid.org/0000-0002-6742-820X)
- Patricia Bastick
- Kristina Zlatic
- Kar Ven Cavan Chow (ORCID: https://orcid.org/0000-0001-8726-4428)
- Andrew Weickhardt (ORCID: https://orcid.org/0000-0002-6482-9681)
- Annabel Smith (ORCID: https://orcid.org/0000-0002-0860-4111)
- Ciara Conduit (ORCID: https://orcid.org/0000-0001-5258-4130)
- David Campbell (ORCID: https://orcid.org/0000-0001-6298-2159)
- Jeffrey C. Goh (ORCID: https://orcid.org/0000-0002-1681-0484)
- Sophie E O'Haire
- Ganes Pranavan
- Ming Wong
- Ben Tran
- Shirley Wong
- Peter Gibbs
Institutions
- Barwon Health (AU)
- The University of Queensland (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Royal Brisbane and Women's Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- Canberra Hospital (AU)
- Royal Hobart Hospital (AU)
- St Vincent's Hospital Melbourne (AU)
- Cancer Australia (AU)
- Chris O’Brien Lifehouse (AU)
- Eastern Health (AU)
- Western Health (AU)
- Monash Health (AU)
- Centre for Cancer Biology (AU)
- Calvary Mater Newcastle Hospital (AU)
- Olivia Newton-John Cancer Wellness & Research Centre (AU)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1111/ajco.70083
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- University of Queensland
- Astellas Pharma